KR101160730B1 - The egg containing selenium, astaxanthin and DHA and its production method - Google Patents
The egg containing selenium, astaxanthin and DHA and its production method Download PDFInfo
- Publication number
- KR101160730B1 KR101160730B1 KR1020090076042A KR20090076042A KR101160730B1 KR 101160730 B1 KR101160730 B1 KR 101160730B1 KR 1020090076042 A KR1020090076042 A KR 1020090076042A KR 20090076042 A KR20090076042 A KR 20090076042A KR 101160730 B1 KR101160730 B1 KR 101160730B1
- Authority
- KR
- South Korea
- Prior art keywords
- selenium
- astaxanthin
- egg
- dha
- water
- Prior art date
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 53
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 52
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 32
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 32
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 32
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 32
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 title claims abstract 3
- 235000013601 eggs Nutrition 0.000 claims abstract description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 56
- 235000011649 selenium Nutrition 0.000 claims abstract description 51
- 239000000440 bentonite Substances 0.000 claims abstract description 32
- 229910000278 bentonite Inorganic materials 0.000 claims abstract description 32
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims abstract description 32
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 29
- 239000011707 mineral Substances 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 24
- 229910052900 illite Inorganic materials 0.000 claims abstract description 20
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 claims abstract description 20
- 229910052613 tourmaline Inorganic materials 0.000 claims abstract description 17
- 229940070527 tourmaline Drugs 0.000 claims abstract description 17
- 239000011032 tourmaline Substances 0.000 claims abstract description 17
- 241000238366 Cephalopoda Species 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 15
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 14
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 13
- 229940065287 selenium compound Drugs 0.000 claims abstract description 12
- 150000003343 selenium compounds Chemical class 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 230000001937 non-anti-biotic effect Effects 0.000 claims abstract description 9
- 240000004160 Capsicum annuum Species 0.000 claims abstract description 8
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims abstract description 8
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 8
- 235000009337 Spinacia oleracea Nutrition 0.000 claims abstract description 8
- 244000300264 Spinacia oleracea Species 0.000 claims abstract description 8
- 239000001511 capsicum annuum Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 7
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 7
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 7
- 241000371652 Curvularia clavata Species 0.000 claims abstract description 7
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 7
- 244000000626 Daucus carota Species 0.000 claims abstract description 7
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 7
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 7
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 7
- 235000013976 turmeric Nutrition 0.000 claims abstract description 7
- 244000163122 Curcuma domestica Species 0.000 claims abstract 2
- 235000007215 black sesame Nutrition 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 240000009300 Apodytes dimidiata Species 0.000 claims description 2
- 210000002969 egg yolk Anatomy 0.000 abstract description 27
- 235000010755 mineral Nutrition 0.000 abstract description 27
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract description 24
- 102000002322 Egg Proteins Human genes 0.000 abstract description 19
- 108010000912 Egg Proteins Proteins 0.000 abstract description 19
- 235000013345 egg yolk Nutrition 0.000 abstract description 15
- 235000013305 food Nutrition 0.000 abstract description 13
- 244000144730 Amygdalus persica Species 0.000 abstract description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract description 4
- 239000000052 vinegar Substances 0.000 abstract description 3
- 235000021419 vinegar Nutrition 0.000 abstract description 3
- 244000000231 Sesamum indicum Species 0.000 abstract description 2
- 235000003434 Sesamum indicum Nutrition 0.000 abstract description 2
- 230000035943 smell Effects 0.000 abstract 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 46
- 229940091258 selenium supplement Drugs 0.000 description 45
- 229940090949 docosahexaenoic acid Drugs 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- 239000003963 antioxidant agent Substances 0.000 description 13
- 235000006708 antioxidants Nutrition 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000003651 drinking water Substances 0.000 description 12
- 235000020188 drinking water Nutrition 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 239000011133 lead Substances 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 7
- 235000014103 egg white Nutrition 0.000 description 7
- 210000000969 egg white Anatomy 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 244000008991 Curcuma longa Species 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 4
- 206010027439 Metal poisoning Diseases 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 4
- 229910001617 alkaline earth metal chloride Inorganic materials 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 208000008127 lead poisoning Diseases 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 150000001342 alkaline earth metals Chemical class 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 229910052793 cadmium Inorganic materials 0.000 description 3
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229920001600 hydrophobic polymer Polymers 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- -1 lipid peroxide Chemical class 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000020830 overeating Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000002341 toxic gas Substances 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 235000008210 xanthophylls Nutrition 0.000 description 2
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010001103 Glutathione oxidase Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 101100366137 Mesembryanthemum crystallinum SODCC.1 gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 101100096142 Panax ginseng SODCC gene Proteins 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038063 Rectal haemorrhage Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940043215 aminolevulinate Drugs 0.000 description 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000013605 boiled eggs Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020974 cholesterol intake Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000000992 latebra Anatomy 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229940072417 peroxidase Drugs 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- SPVXKVOXSXTJOY-UHFFFAOYSA-N selane Chemical compound [SeH2] SPVXKVOXSXTJOY-UHFFFAOYSA-N 0.000 description 1
- 229910000058 selane Inorganic materials 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 101150017120 sod gene Proteins 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L15/00—Egg products; Preparation or treatment thereof
- A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Feed For Specific Animals (AREA)
Abstract
본 발명은 계란 특유의 비린내가 없으며, 셀레늄, 아스타산친 및 DHA를 함유하는 계란 및 이의 생산방법에 관한 것으로, 껍질을 제외한 계란 100g당 DHA 25.0 ~100mg, 셀레늄 0.05 ~0.5mg, 아스타산친 0.5 ~5mg을 함유하는 계란으로서 토르말린, 일라이트, 벤토나이트 중 적어도 1종을 황산반토처리하고 클러스터화된 물에 투입하여 미네랄을 용출시킨 미네랄수에 알칼리이온수를 혼합하여 pH를 6.5 ~ 7.0으로 조절한 음용수를 1일 산란계 마리당 100 ~ 200cc를 음용하게 하고, 무항생제 사료 중량에 대하여 일라이트 또는 벤토나이트 분말 1 ~ 5%, 셀레늄화합물 0.01 ~ 1% 및 아스타산친 0.01 ~ 1%를 혼합한 사료를 식이케하고, 필요에 따라 무항생제 사료 중량에 대하여 오징어, 보리, 파프리카, 자고, 서리태, 강황, 당근, 천연, 서리, 쑥, 뽕잎, 시금치, 흑미, 오징어먹물, 검은깨, 쓴메밀, 백화사설초, 꾸지뽕나무 각각의 분말로 구성되는 군으로부터 선택된 분말을 적어도 1종 이상 혼합한 보조 사료 1 ~ 2%를 혼합하여 식이케함으로써 계란 특유의 비린내가 없으며, 셀레늄, 아스타산친 및 DHA를 함유하고 적색, 흑색, 홍색, 녹색 등으로 착색된 난황을 갖는 계란을 용이하게 생산할 수 있다.The present invention does not have a unique fishy smell, and relates to an egg containing selenium, astaxanthin and DHA, and a method for producing the same, which contains DHA 25.0 to 100 mg, selenium 0.05 to 0.5 mg, and astaxanthin 0.5 to 5 mg per 100 g of egg without shells. As the eggs, at least one of tourmaline, illite, and bentonite is treated with alumina sulfate and added to clustered water, and mixed with alkaline ionized water to mineral water eluted from mineral water. Drink 100 to 200 cc per horse, and feed the mixture of 1 to 5% of elite or bentonite powder, 0.01 to 1% of selenium compound, and 0.01 to 1% of astaxanthin based on the weight of non-antibiotic feed. Squid, barley, paprika, sleeping, frosted, turmeric, carrot, natural, frost, mugwort, mulberry leaves, spinach, black rice, squid ink, There are no fishy smells unique to eggs by mixing 1 ~ 2% of supplementary foods mixed with at least one powder selected from the group consisting of sesame, bitter buckwheat, white peach vinegar, and koji mulberry powder, selenium, astaxanthin and Eggs containing DHA and having egg yolk colored red, black, red, green and the like can be easily produced.
Description
본 발명은 계란 특유의 비린내가 없으며, 셀레늄, 아스타산친 및 DHA를 함유하는 계란 및 이의 생산방법에 관한 것으로, 좀 더 구체적으로는 껍질을 제외한 계란 100g당 DHA 25.0 ~100mg, 셀레늄 0.05 ~0.5mg, 아스타산친 0.5 ~5mg을 함유하는 계란으로서 토르말린, 일라이트, 벤토나이트 중 적어도 1종을 황산반토처리하고 클러스터화된 물에 투입하여 미네랄을 용출시킨 미네랄수에 알칼리이온수를 혼합하여 pH를 6.5 ~ 7.0으로 조절한 음용수를 1일 산란계 마리당 100 ~ 200cc를 음용하게 하고, 무항생제 사료 중량에 대하여 일라이트 또는 벤토나이트 분말 1 ~ 5%, 셀레늄화합물 0.01 ~ 1% 및 아스타산친 0.01 ~ 1%를 혼합한 사료를 식이케하고, 필요에 따라 무항생제 사료 중량에 대하여 오징어, 보리, 파프리카, 자고, 서리태, 강황, 당근, 천연, 서리, 쑥, 뽕잎, 시금치, 흑미, 오징어먹물, 검은깨, 쓴메밀, 백화사설초, 꾸지뽕나무 각각의 분말로 구성되는 군으로부터 선택된 분말을 적어도 1종 이상 혼합한 보조 사료 1 ~ 2%를 혼합하여 식이케함으로써 계란 특유의 비린내가 없으며, 셀레늄, 아스타산친 및 DHA를 함유하고 적색, 흑색, 홍색, 녹색 등으로 착색된 난황을 갖는 계란 및 이의 생산방법에 관한 것이다.The present invention relates to an egg that does not have a unique fishy smell and contains selenium, astaxanthin and DHA, and a method for producing the same. More specifically, DHA 25.0 to 100 mg, selenium 0.05 to 0.5 mg, and astaxanthin per 100 g of eggs except shells. An egg containing 0.5 to 5 mg, at least one of tourmaline, illite and bentonite was treated with alumina sulfate and added to clustered water to mix pH of the mineral eluted with alkali water to adjust the pH to 6.5 to 7.0. Drink drinking water at 100 to 200 cc per laying hen per day, and feed the mixture containing 1 to 5% of elite or bentonite powder, 0.01 to 1% of selenium compound and 0.01 to 1% of astaxanthin based on the weight of non-antibiotic feed. Squid, barley, paprika, sleeping, frosted, turmeric, carrot, natural, frost, mugwort, mulberry leaf, spinach, The unique fishy smell of eggs by mixing 1 ~ 2% of supplementary foods mixed with at least one powder selected from the group consisting of black rice, squid ink, black sesame, bitter buckwheat, white peach vinegar, and koji mulberry powder The present invention relates to an egg containing selenium, astaxanthin and DHA and having egg yolk colored in red, black, red, green, and the like and a method of producing the same.
계란은 닭이 낳은 알로써 겉은 단단한 껍데기(난각)에 싸여 있고, 그 안에는 2층의 속껍질이 있다. 겉껍데기에는 작은 구멍이 많아서 그 구멍을 통하여 호흡을 하며, 시간이 지나면 이 구멍을 통하여 이산화탄소와 수분이 증발하고, 미생물이 침투하여 내용물이 빨리 썩게 된다. 2층으로 된 속껍질 사이의 한쪽에는 공기집이 있는데, 이 공기집은 갓 낳은 달걀일 때는 작았다가 시간이 지나 수분과 이산화탄소가 증발하면 차차 커진다.Eggs are eggs laid by chickens and wrapped in hard shells (eggs) on the inside, with two layers of shells inside. There are many small holes in the outer shell and breathe through them. Over time, carbon dioxide and water evaporate through these holes, and microorganisms penetrate and the contents quickly decay. There is an air trap on one side between the two-layered shells, which is small for freshly laid eggs and grows over time as water and carbon dioxide evaporate.
속껍질 안에는 흰자위(난백)이 있고 겉껍데기와 노른자위(난황) 주위에는 묽은 흰자위가 있으며, 그 중간에는 된 흰자위가 있고, 노른자위는 얇은 막으로 둘러싸여 있고 양쪽 끝이 알끈으로 고정되어 있다. 각 구성 물질의 평균적인 비율은 껍데기 11%, 흰자위 58%, 노른자위 31%이다.In the inner shell there is a white egg (an egg white), around the outer shell and yolk (an egg yolk) there is a thin white egg, in the middle of it is a white egg, the yolk is surrounded by a thin film and both ends are fixed with a string. The average proportion of each component is 11% shell, 58% white and 31% yolk.
계란의 특징은 높은 영양가에 비해 에너지가 낮고, 소화 흡수가 잘 되며, 가격이 비교적 저렴하고, 계란 단백질은 다른 식품의 단백질을 평가하는데 표준품으로 사용될 정도로 조성과 품질이 우수하다. 식품에 함유된 단백질의 품질은 생물가(biological value)로 표기되며, 성장에 필요한 필수 아미노산 조성면에서 볼 때 모유 다음으로 계란이 높다.Eggs are characterized by low energy, good digestion and absorption, relatively low price compared to high nutritional value, and egg protein, which is excellent in composition and quality so that it can be used as a standard for evaluating proteins in other foods. The quality of protein in food is expressed in biological values, and eggs are the second highest after breast milk in terms of the essential amino acid composition needed for growth.
계란은 난백과 난황의 영양적 조성이 완전히 다르며, 전체적인 영양적 조성을 보면 일반 성분, 지방산, 무기질, 아미노산 조성에서 풍부한 영양가를 함유하고 있고, 난백은 90%의 수분과 나머지 단백질과 소량의 탄수화물이 들어 있으며 지방이 없는 것이 특징인 데 비해 전 중량의 1/3을 차지하고 있는 난황은 지방이 들어 있어 열량이 높다. 난황 단백질도 난백만큼 함유되어 있으며, 계란의 비타민과 무기질도 대부분 난황에 들어 있다. 탄수화물은 1%내외로 난백에 소량 들어 있다.Eggs have a completely different nutritional composition of egg whites and egg yolks.The nutritional composition of the whole egg contains abundant nutritional value in general ingredients, fatty acids, minerals and amino acids, and egg whites contain 90% water and the remaining protein and a small amount of carbohydrates. It is characterized by no fat, but egg yolk, which accounts for one third of the total weight, contains high fat because it contains fat. Egg yolk contains as much protein as egg white, and most of the vitamins and minerals in eggs are found in yolk. Carbohydrates are found in egg whites at around 1%.
계란은 양질의 단백질은 물론 비타민과 미네랄까지 영양 면에서 어느 것 하나 손색이 없어 완전식품이라 불린다. 덕분에 남녀노소를 막론하고 가능한 한 많이 먹을수록 좋은 식품, 특히 성장기 어린이에게 꼭 필요한 것으로 알려져 있다.Eggs are called perfect foods because they are not only good quality protein, but also vitamins and minerals. Thanks to this, eating as much as possible, regardless of age or gender, is known to be a good food, especially for growing children.
한편, 일부 사람들이 달걀을 꺼리는 데, 그 하나의 이유는 콜레스테롤 때문이다. 보통 계란 한 개에 들어 있는 콜레스테롤 양은 250mg, 세계보건기구(WHO)가 권장하는 정상인 하루 콜레스테롤 섭취량 300mg에 육박한다. 따라서, 오랜 기간에 걸쳐 많이 먹으면 혈중 콜레스테롤을 지나치게 높여 동맥경화 심장병 등을 일으키기도 한다.On the other hand, some people are reluctant to eat eggs because of cholesterol. The amount of cholesterol in an egg is usually around 250mg, which is 300mg of normal daily cholesterol intake recommended by the World Health Organization (WHO). Therefore, eating a lot over a long period of time too high blood cholesterol can cause arteriosclerosis heart disease.
그러나, 심장질환 걱정에 달걀을 피하는 것은 기우에 지나지 않는다. 한국인의 경우 평균 달걀 섭취량은 하루 한 개에 불과하고, 달걀 노른자에 풍부한 레시틴은 혈중 콜레스테롤이 높아지는 것을 막아주기 때문이다. 레시틴은 필수지방산인 비타민 F와 인, 콜린, 이노시톨이 결합된 복합물질로 혈중 콜레스테롤을 분해해 에너지로 전환시킨다. 때문에 콜레스테롤 농도를 낮추고 간에 지방이 쌓이는 것도 막아준다.However, avoiding eggs is a worrisome concern for heart disease. In Korea, the average egg intake is only one, and lecithin, which is rich in egg yolk, prevents blood cholesterol from increasing. Lecithin is a combination of essential fatty acids, vitamin F, phosphorus, choline, and inositol, which break down blood cholesterol and convert it into energy. This lowers cholesterol levels and prevents liver fat buildup.
계란은 단백질의 영양을 비교해 수치로 나타낸 단백가(protein score)가 100에 해당하는 양질의 단백질로 우유(78)나 쇠고기(83)보다 훨씬 고급이다. 라이신, 메티오닌, 트립토판 등 필수아미노산을 골고루 갖고 있고, 특히 흰자의 알부민과 노른자의 비텔린 등은 세포 생성에 중요한 작용을 해 생명 합성의 기본이 된다. 또 한, 독을 흡수하는 성질이 있어 음주 후에도 날계란을 풀어 먹으면 술 깨는 데 도움이 된다. 레시틴을 이루는 물질 중 하나인 콜린은 신경전달물질 합성에 관여해 치매 예방에도 효과적이다. 노른자에는 지방도 풍부한데 소화율이 98%에 달해 위에 부담을 주지 않는다.Eggs are high quality proteins with a protein score of 100 compared to the nutritional value of proteins, much higher than milk (78) or beef (83). Essential amino acids such as lysine, methionine, and tryptophan are evenly distributed. Especially albumin and yolk bitelin of whites play an important role in cell production and become the basis of biosynthesis. In addition, it has the property of absorbing poison, so even after drinking raw eggs to help you drink alcohol. Choline, one of the lecithin-forming substances, is also effective in preventing dementia by participating in the synthesis of neurotransmitters. The yolk is rich in fat, but its digestibility reaches 98%, which does not burden the stomach.
뿐만 아니라, 계란에 다량 들어 있는 비타민 A, B, B6, B12, E와 엽산(folate) 등은 심장질환 위험 인자인 혈중 호모시스테인(homocysteine) 농도를 낮추는 작용을 한다고 알려져 있다. 칼슘, 철분 등 미네랄도 우유나 시금치 등의 채소에 조금도 뒤지지 않는다. 부족한 것은 비타민 C뿐이다.In addition, vitamins A, B, B 6 , B 12 , E and folate contained in large amounts in eggs are known to lower blood homocysteine levels, a risk factor for heart disease. Minerals such as calcium and iron do not lag behind vegetables such as milk or spinach. The only thing lacked is vitamin C.
다이어트에 대한 관심을 끊을 수 없는 여성에게도 계란은 좋은 식품으로써, 삶은 계란 1개의 열량은 80kcal밖에 안 되지만 위에 머무르는 시간이 3시간 15분이나 되기 때문에 포만감을 주어 과식을 방지할 수 있다. Eggs are a good food for women who can not stop their interest in the diet, the calories of one boiled egg is only 80kcal, but the time to stay in the stomach for three hours and 15 minutes to prevent overeating.
신선한 달걀은 껍데기가 까칠까칠하고 깨뜨렸을 때 껍데기와 분리도 잘 된다. 노른자가 퍼지지 않고 도톰하게 올라오고 탄력 있는 것이 좋다. 대부분의 소비자가 노른자 색이 진할수록 선호하지만 노른자의 색은 영양과 관계없다. 노른자의 색은 단풍잎을 노랗게 물들이는 성분인 크산토필 함량과 닭의 건강상태에 따라 좌우된다. 최근에는 소비자 선호도에 따라 크산토필이 많이 들어간 사료를 사용하는 경우도 많다.Fresh eggs can be separated from the shell when they are cracked and broken. The yolk does not spread and comes thicker and more elastic. Most consumers prefer the darker yolk color, but the yolk color is not related to nutrition. The color of the yolk depends on the content of xanthophyll, a component of yellowing maple leaves, and the health of the chicken. Recently, according to consumer preferences, many foods containing xanthophyll are often used.
한편, 활성산소로 인해 우리 몸이 노화되고 손상되는 것을 막아주는 물질을 항산화물질(antioxidants)이라고 하고, 항산화물질은 인체 내에 자연적으로 존재하 는 것과 외부에서 투여해 주는 것으로 나눌 수 있다.On the other hand, the substances that prevent the body from aging and damage due to free radicals are called antioxidants (antioxidants), antioxidants can be divided into those that are naturally present in the human body and administered externally.
인체 내에 자연적으로 존재하는 항산화제로는 SOD, 글루타치온, 페록시다제 등의 효소와 요산, 빌리루빈 등이 있으며, 외부에서 투여해 주는 것으로 비타민 E, C, 베타카로틴이 있고, 미네랄 중에는 셀레늄이 대표적이다. 그 밖에도 멜라토닌 같은 호르몬, 녹차에 많이 들어 있는 플라보노이드 성분과 적포도주에 들어 있는 폴리페놀, 벌집을 구성하는 성분의 하나인 프로폴리스 등이 대표적인 항산화물질들이다.Antioxidants naturally present in the human body include enzymes such as SOD, glutathione, and peroxidase, uric acid, and bilirubin, and are administered externally, such as vitamin E, C, beta-carotene, and selenium is a representative mineral. Other antioxidants include hormones such as melatonin, flavonoids in green tea, polyphenols in red wine, and propolis, one of the components of honeycomb.
이들 항산화물질들은 활성산소의 독작용을 제거하여 생체를 보호하고 있으며 항산화 물질이 활성산소를 적절히 제거하지 못할 경우 축적되는 활성산소에 의해 여러 가지 질병이나 노화가 초래된다.These antioxidants protect the living body by eliminating the poisoning of free radicals, and various diseases and aging are caused by free radicals that accumulate when antioxidants do not properly remove free radicals.
또한, 셀레늄은 원소 주기율표상 VI B족에 속하는 산소족 원소로서, 맥주효모, 돼지나 소의 콩팥, 버터, 소맥배아, 굴, 새우, 우유, 현미나 마늘 등에 상당량 함유되어 있으며, 사람이나 동물 체내에서는 셀레노아미노산으로도 존재하고, 세포막의 손상을 야기하는 활성산소를 제어하는 작용을 가진 글루타치온퍼옥시다제를 활성화함으로써 세포막의 손상을 방지하여 노화를 지연시킬 뿐만 아니라 종양성 질환을 예방하는 작용을 가진 것으로 알려져 있다. 많은 연구에서 셀레늄은 종양질환을 억제하는 효과가 있는 것으로 발표되고 있는데, 이는 많은 암환자에서 혈청내 셀레늄 농도가 비정상적으로 낮게 나타나는 것으로도 확인할 수 있다.In addition, selenium is an oxygen group element belonging to group VI B of the periodic table of elements, and contains a significant amount of beer yeast, pork or bovine kidney, butter, wheat germ, oyster, shrimp, milk, brown rice, garlic, etc. It also acts as a noamino acid and acts as a glutathione peroxidase that controls the free radicals that cause damage to the cell membranes, thereby preventing damage to the cell membranes, delaying aging and preventing tumor diseases. Known. In many studies, selenium has been shown to have an inhibitory effect on tumor disease, which can be seen in many cancer patients with abnormally low levels of serum selenium.
또한, 납중독에 의한 빈혈 현상은 납이 적혈구의 용혈작용과 헤모글로빈 합성에 관여하는 S-아미노레불린산데하이드라제(ALAD) 효소의 활성을 저해하여 아미 노레불린산의 뇨배설을 증가시킴으로써 조혈작용을 저해할 뿐 아니라, 납이 ALAD의 SH기를 불활성화시켜 조혈기능이 악화됨으로써 발생하는 것으로 알려져 있다. 이러한 납중독은 생체내 항산화제로 알려진 셀레늄에 의해 해독될 수 있다는 보고가 있는데, 이는 납에 의해 활성이 약화된 셀레늄-의존성 항산화계 효소인 글루타치온퍼옥시다제가 셀레늄 보충으로 그 활성이 현저하게 증가되기 때문이다. 이는 흰쥐의 납중독시에 식이내 셀레늄을 0.5ppm의 농도로 첨가하면 비첨가군에 비하여 간장조직의 과산화적 손상이 감소되는 것으로부터 입증되고 있다.In addition, anemia caused by lead poisoning is hematopoietic by increasing the urinary excretion of aminolevulinic acid by inhibiting the activity of S-aminolevulinate dehydrase (ALAD) enzyme, which is involved in hemolysis of hemoglobin and hemoglobin synthesis. In addition to inhibiting, it is known that lead is caused by inactivation of the SH group of ALAD and deterioration of hematopoietic function. It has been reported that lead poisoning can be detoxified by selenium, which is known as an antioxidant in vivo, because glutathione peroxidase, a selenium-dependent antioxidant enzyme whose activity is weakened by lead, is significantly increased by selenium supplementation. to be. This was proved by adding 0.5 ppm of dietary selenium to lead poisoning in rats, which reduced the peroxidative damage of hepatic tissues compared to the non-added group.
셀레늄의 이러한 납중독 해독작용은 ALAD의 SH기가 Se로 치환됨으로써 납에 의한 SH기의 불활성화가 방지되기 때문인 것으로 설명되고 있다. 기타 유사한 기전에 의해 셀레늄은 납 이외에도 카드뮴, 수은 등의 중금속 해독작용을 나타내는 것으로 보고되어 있다.This lead poisoning detoxification action of selenium is explained because the SH group of ALAD is replaced with Se, thereby preventing the inactivation of SH group by lead. Other similar mechanisms have reported that selenium exhibits heavy metal detoxification effects such as cadmium and mercury in addition to lead.
특히, 이들 셀레늄은 암을 비롯한 여러가지 종양성 질환을 예방하는 성질을 갖고 있으며, 동물실험에 의하여 쥐에 셀레늄을 식이로 섭취시켰을 경우, 암발생을 40 ~ 60% 감소시켰다는 결과와 유방암 환자의 경우 혈액 내 셀레늄 농도와 암발생In particular, these selenium has a property of preventing various tumorous diseases including cancer, and when the intake of selenium in rats by animal experiments reduced the incidence of cancer by 40 to 60% and blood in breast cancer patients Selenium concentration and cancer
빈도가 반비례한다는 결과가 보고되어 있다.It is reported that the frequency is inversely proportional.
셀레늄의 우수한 작용효과를 살펴보면, 셀레늄의 항산화력은 비타민 E의 1970배에 달하며 비타민 E와 셀레늄을 병용하면 항산화력은 상승효과가 나타나고, 비듬과 건선을 치료하는 효과가 있으며, 비타민 C 및 E와 같이 불포화 지방산의 산화를 억제하여 과산화 지질의 생성을 억제할 뿐만 아니라 과산화 지질과 단백질의 결합물인 노폐물질을 분해하여 인체의 노화를 억제시키고, 수은, 카드뮴, 납 등의 중금속과 결합하여 이들을 불활성화시키고 간세포의 괴사를 방지하여 간경화증을 예방하며, 암을 예방하며 면역기능을 향상시키고 상당량(약 25 내지 40%)이 고환, 정낭, 전립선 등 성기관에 집중되어 성적기능을 향상시키고, 백내장과 류마티즘을 예방하여 비타민 E와 함께 근이양중을 치료한다.Looking at the excellent effect of selenium, the antioxidant power of selenium is 1970 times of vitamin E. When used together with vitamin E and selenium, the antioxidant effect is synergistic, and it is effective in treating dandruff and psoriasis. As well as inhibiting the oxidation of unsaturated fatty acids to inhibit the production of lipid peroxide, as well as decomposing waste materials, which are a combination of lipid peroxide and protein, inhibits aging of the human body and binds to heavy metals such as mercury, cadmium and lead to inactivate them. To prevent liver cirrhosis, to prevent liver cirrhosis, to prevent cancer, to improve immune function, and a significant amount (about 25 to 40%) is concentrated in sexual organs such as testes, seminal vesicles, prostate, etc. to improve sexual function, cataract and rheumatism Treat muscle dysfunction with vitamin E by preventing
우리 나라 토양은 셀레늄 함량이 극도로 희박한 나라로서 셀레늄 함량이 높은 나라의 30% 정도에 그치고 있어, 재배되는 농작물에 축적되는 셀레늄의 양도 극히 미약하므로 별도의 셀레늄 공급원이 필요한 실정이다.The soil of our country is extremely rare in the selenium content, only about 30% of the country with a high selenium content, the amount of selenium accumulated in the cultivated crops is very small, so a separate source of selenium is needed.
특히, 셀레늄은 은, 구리, 납, 니켈 등과 같은 미네랄과 결합된 것, 소듐 셀레나이트, 소듐 셀레네이트 등과 같이 산소와 결합된 것, 하이드로겐 셀레나이드 등과 같은 무기 셀레늄과 효모, 유산균 등의 미생물을 배양시 무기 셀레늄을 공급하여 세포내 생체반응을 통하여 아미노산과 황과 셀레늄이 치환된 아미노산 결합형인 유기 셀레늄으로 구분되는 데, 무기 셀레늄은 흡수성이 좋지 않을 뿐만 아니라 독성이 있고 부작용이 있어 사람은 물론 동물에 직접 적용할 수 없어 유기 셀레늄을 제공하여야 한다.In particular, selenium is combined with minerals such as silver, copper, lead, nickel, and the like, oxygen-bonded ones such as sodium selenite and sodium selenate, inorganic selenium such as hydrogen selenide, and microorganisms such as yeast and lactic acid bacteria. Inorganic selenium is supplied in culture and is divided into amino acid, organic selenium which is an amino acid binding type substituted with sulfur and selenium through intracellular reaction. Inorganic selenium is not only absorbent but also toxic and has side effects. Organic selenium should be provided because it cannot be applied directly.
그리고, DHA(Docosa Hexaenoic Acid)는 오메가3 불포화 지방산의 일종이고, 두뇌 세포의 가장 중요한 구성 성분으로 "두뇌 활성 물질"로 알려져 있으며, 사람의 뇌 세포막은 지방 60% , DHA 성분 30%로 되어 있는데 DHA는 육류나 채소류 등에 거의 존재하지 않고 또한 체내에서 자발적으로 생산되지도 않기 때문에 반드시 외부로부터 공급되어져야 하는 특성이 있다.In addition, DHA (Docosa Hexaenoic Acid) is a type of omega-3 unsaturated fatty acid, known as the "brain active substance" as the most important component of brain cells, human brain cell membrane is 60% fat, 30% DHA component Since DHA is hardly present in meat or vegetables, and is not produced spontaneously in the body, it has to be supplied from the outside.
DHA성분은 학습능력과 기억력을 유지 강화하는 데 매우 유용한 불포화 지방 산으로, 뇌세포의 막 구조를 소프트하게 유지시켜 정보의 전달 속도를 높혀 기억력과 학습 능력을 향상시키는 작용을 하며, 산모에게 DHA가 부족할 경우 미숙아를 출산할 가능성이 높아지며 아이들의 경우 학습 장애를 유발하고 또한 노인 분들은 치매가 빨리 올 수도 있는 것으로 알려져 있고, DHA는 망막을 이루는 중요 성분으로 부족할 경우 시력이 나빠지고 퇴화가 빠르게 진행될 수 있으며 눈의 피로를 가중하는 것으로 알려져 있다.DHA is an unsaturated fatty acid which is very useful for maintaining and strengthening the learning ability and memory. It keeps the membrane structure of brain cells soft and increases the speed of information transfer, improving memory and learning ability. Lack of birth increases the likelihood of giving birth to premature infants, causes learning disabilities in children, and is also known to cause dementia in older people. DHA is an important component of the retina, which can lead to poor eyesight and rapid degeneration. It is known to increase eye fatigue.
따라서, 본 발명의 목적은 계란 특유의 비린내가 없으며, 아스타산친, 셀레늄 및 DHA를 함유하는 계란 요리의 섭취만으로도 높은 셀레늄, 항산화물질 및 DHA흡수 효과를 얻어 아스타산친, 셀레늄 및 DHA가 갖는 효과를 발현시킬 수 있는 계란을 제공하는 데 있다.Therefore, the object of the present invention is not the fishy smell unique to eggs, it is possible to express the effects of astaxanthin, selenium and DHA by obtaining a high selenium, antioxidant and DHA absorption effect only by the intake of egg dishes containing astaxanthin, selenium and DHA It is to provide an egg.
본 발명의 다른 목적은 난황을 착색시킴으로써 착색된 색상을 요하는 요리에 사용될 수 있을 뿐만 아니라 어린이들에게 호기심을 유발하여 계란의 섭취를 용이하게 할 수 있는 착색 난황 계란을 제공하는 데 있다.Another object of the present invention is to provide a colored egg yolk egg which can be used for cooking requiring colored color by coloring egg yolk as well as inducing children's curiosity to facilitate the ingestion of eggs.
본 발명의 또 다른 목적은 상기 목적들의 계란을 용이하게 생산하는 방법을 제공하는 데 있다. Still another object of the present invention is to provide a method for producing eggs easily.
상기 목적 뿐만 아니라 용이하게 표출될 수 있는 또 다른 목적들을 달성하기 위하여 본 발명에서는 토르말린, 일라이트, 벤토나이트 중 적어도 1종을 황산반토처리하고 클러스터화된 물에 투입하여 미네랄을 용출시킨 미네랄수에 알칼리이온수를 혼합하여 pH를 6.5 ~ 7.0으로 조절한 음용수를 1일 산란계 마리당 100 ~ 200cc를 음용하게 하고, 무항생제 사료 중량에 대하여 일라이트 또는 벤토나이트 분말 1 ~ 5%, 셀레늄화합물 0.01 ~ 1% 및 아스타산친 0.01 ~ 1%를 혼합한 사료를 식이케하고, 필요에 따라 무항생제 사료 중량에 대하여 오징어, 보리, 파프리카, 자고, 서리태, 강황, 당근, 천연, 서리, 쑥, 뽕잎, 시금치, 흑미, 오징어먹물, 검은깨, 쓴메밀, 백화사설초, 꾸지뽕나무 각각의 분말로 구성되는 군으로부터 선택된 분말을 적어도 1종 이상 혼합한 보조 사료 1 ~ 2%를 혼합하여 식이케함으로써 계란 특유의 비린내가 없으며, 껍질을 제외한 계란 100g당 DHA 25.0 ~100mg, 셀레늄 0.05 ~0.5mg, 아스타산친 0.5 ~5mg을 함유하고, 적색, 흑색, 홍색, 녹색 등으로 착색된 난황을 갖는 계란을 용이하게 생산할 수 있었다.In order to achieve the above object as well as other objects that can be easily expressed in the present invention, at least one of tourmaline, illite, bentonite is treated with alumina sulfate and added to clustered water, and alkali is dissolved in mineral water. Drinking water adjusted to pH 6.5-7.0 by mixing ionized water was made to drink 100-200cc per laying hen per day, 1-5% illite or bentonite powder, 0.01-1% selenium compound and astaxanthin based on the weight of non-antibiotic feed. Diet the mixture of 0.01 to 1%, and if necessary, squid, barley, paprika, sleeping, frosted, turmeric, carrot, natural, frost, mugwort, mulberry leaf, spinach, black rice, squid ink Supplementary mixture of at least one powder selected from the group consisting of black sesame seeds, bitter buckwheat, white peach, and koji mulberry powder It is made by mixing 1 ~ 2% of ingredients and has no peculiar fishy smell.It contains DHA 25.0 ~ 100mg, selenium 0.05 ~ 0.5mg, astaxanthin 0.5 ~ 5mg per 100g egg without shell, red, black, red, green Eggs with egg yolk colored with or the like could be easily produced.
본 발명에 따른 계란은 계란 특유의 비린내가 없으며, 껍질을 제외한 계란 100g당 DHA 25.0 ~100mg, 셀레늄 0.05 ~0.5mg, 아스타산친 0.5 ~5mg을 함유하여 아스타산친, 셀레늄 및 DHA를 함유하여 계란 요리의 섭취만으로도 높은 아스타산친, 셀레늄 및 DHA 흡수 효과를 얻어 아스타산친, 셀레늄 및 DHA가 갖는 효과를 발현시킬 수 있고, 난황을 착색시킴으로써 착색된 색상을 요하는 요리에 사용될 수 있을 뿐만 아니라 어린이들에게 호기심을 유발하여 계란의 섭취를 용이하게 할 수 있는 효과가 있다.Eggs according to the present invention do not have a unique fishy smell, and contain 100 mg of DHA 25.0 to 100 mg, selenium 0.05 to 0.5 mg, and astaxanthin 0.5 to 5 mg per 100 g of eggs excluding shells, and contain astaxanthin, selenium and DHA. It can get high astaxanthin, selenium and DHA absorption effect to express the effect of astaxanthin, selenium and DHA, and it can be used for cooking that requires colored color by coloring egg yolk, and it also induces curiosity in children. There is an effect that can facilitate the intake.
본 발명에 따른 아스타산친, 셀레늄 및 DHA를 함유하여 계란은 껍질을 제외한 계란 100g당 DHA 25.0 ~100mg, 셀레늄 0.05 ~0.5mg, 아스타산친 0.5 ~5mg을 함유하는 것으로 특징지워진다.Astaxanthin, selenium and DHA according to the present invention, the egg is characterized by containing 25.0 to 100 mg of DHA, 0.05 to 0.5 mg of selenium, and 0.5 to 5 mg of astaxanthin per 100 g of egg without shell.
또한, 본 발명에 따른 아스타산친, 셀레늄 및 DHA를 함유하는 계란의 생산 방법은 토르말린, 일라이트, 벤토나이트 중 적어도 1종을 황산반토처리하고 클러스터화된 물에 투입하여 미네랄을 용출시킨 미네랄수에 알칼리이온수를 혼합하여 pH를 6.5 ~ 7.0으로 조절한 음용수를 1일 산란계 마리당 100 ~ 200cc를 음용하게 하고, 무항생제 사료 중량에 대하여 일라이트 또는 벤토나이트 분말 1 ~ 5%, 셀레늄화합물 0.01 ~ 1% 및 아스타산친 0.01 ~ 1%를 혼합한 사료를 식이케하고, 필요에 따라 무항생제 사료 중량에 대하여 오징어, 보리, 파프리카, 자고, 서리태, 강황, 당근, 천연, 서리, 쑥, 뽕잎, 시금치, 흑미, 오징어먹물, 검은깨, 쓴메밀, 백화사설초, 꾸지뽕나무 각각의 분말로 구성되는 군으로부터 선택된 분말을 적어도 1종 이상 혼합한 보조 사료 1 ~ 2%를 혼합하여 식이케하는 것으로 특징지워진다.In addition, the method for producing eggs containing astaxanthin, selenium and DHA according to the present invention is alkaline ionized water in mineral water in which at least one of tourmaline, illite and bentonite is treated with alumina sulfate and added to clustered water to elute minerals. Mixed with water to make drinking water adjusted to pH 6.5-7.0 per day, 100-200cc per laying hen, 1 ~ 5% of elite or bentonite powder, 0.01-1% selenium compound and 0.01% astaxanthin 0.01 ~ 1% mixed feed, if necessary, on the weight of non-antibiotic feed, squid, barley, paprika, sleeping, frosted, turmeric, carrot, natural, frost, mugwort, mulberry leaf, spinach, black rice, squid ink, Mix 1 ~ 2% of supplementary foods mixed with at least one powder selected from the group consisting of black sesame, bitter buckwheat, white peach vinegar and powder It characterized by over eating cake.
토르말린은 일명 전기석이라 불리는 육방정계에 속하는 광물로서 화학성분은 철, 마그네슘, 알칼리금속 등과 알루미늄의 복잡한 붕규산염이고, 대개는 6각 또는 9각 때로는 3각 주상을 이루며, 주의 상하에서 결정형을 달리하는 경우도 있다. 또, 상하가 편평한 능면체나 침상, 모상을 나타내며, 때로 입상, 괴상을 이루기도 한다. 쪼개짐은 분명하지 않고, 단구는 평탄하지 않거나 패각상이며, 굳기 7.0 ~ 7.5, 비중 2.98 ~ 3.20이고, 유리광택 또는 수지광택이 있다. 마찰에 의해서 전기가 생기며, 가열하면 양끝이 양, 음으로 대전하기 때문에 전기석이라는 이름이 붙여졌고, 철이 많은 것을 철전기석이라 하며, 흑색을 띠며 육안으로는 불투명한 것이 많다.Tourmaline is a mineral belonging to a hexagonal system called a tourmaline, and its chemical composition is a complex borosilicate of iron, magnesium, alkali metals and aluminum, and usually forms a hexagonal or nine-angled and sometimes triangular-shaped column. In some cases. Moreover, it exhibits a flat rhombohedron, a needle, and a parenthesis, and sometimes forms granules or blocks. The cleavage is not clear, the monocytes are not flat or shell-shaped, have a hardness of 7.0 to 7.5, specific gravity of 2.98 to 3.20, and have glass gloss or resin gloss. Electricity is generated by friction, and when heated, both ends are positively and negatively charged, so the tourmaline is named, and many irons are called iron tourmaline, and they are black and many are opaque to the naked eye.
또한, 토르말린은 인체의 모세혈관을 크게하여 혈액순환을 촉진, 세포의 활성화, 신진대사 촉진, 위장운동의 활성화, 온열효과, 피로회복, 신경통, 기미, 냉대하증에 효능이 있는 것으로 알려져 있고, 항산화 작용과 0.06A의 작은 전류가 흘러 발생하는 음이온과 원적외선 상승효과에 따라 다양한 효과를 인체에 결합하여 노화의 원인인 유해한 활성산소를 분해하고 알카리화하여 두통과 얼굴축소, 다이어 트에 큰 효과가 있다는 연구 발표도 있다.In addition, tourmaline is known to be effective in promoting blood circulation by activating capillaries in the human body, activating cells, promoting metabolism, activating gastrointestinal movement, warming effect, fatigue recovery, neuralgia, blemishes, hypothermia, and antioxidant Various effects are combined in the human body according to the action and the negative ion and far infrared synergistic effect generated by the small current of 0.06A, which decomposes and alkalines harmful free radicals that cause aging and has a great effect on headache, face reduction and diet. There is also a research presentation.
한편, 일라이트는 단사정계에 속하는 운모족 광물로써 화학조성은 (K,H3O)Al2(Si,Al)4O10(H2O,OH)2이고, 화학성분으로 볼 때 백운모에 가까운 것도 있으나 비교적 SiO2, MgO, H2O가 많고, K2O는 적으며, 수백운모 등과 같은 계열의 광물이고, 굳기 1 ~ 2, 비중 2.6 ~ 2.9이며, 알루미늄이 풍부한 이질 또는 응회암질 퇴적암 중에 산출되며, 열수성 광상모암의 변질광물로서 산출된다.On the other hand, the illite is a mica-like mineral belonging to the monoclinic system, and its chemical composition is (K, H 3 O) Al 2 (Si, Al) 4 O 10 (H 2 O, OH) 2 , Some are close, but relatively rich in SiO 2 , MgO, H 2 O, few K 2 O, minerals of several hundred mica, etc. It is computed in the middle, and it is computed as the altered mineral of a thermoacoustic deposit.
또한, 일라이트는 중금속 흡착, 유독가스 흡착, 원적외선 방사, 음이온 발생 등에 뛰어난 특성을 지니고 있고, 분자구조가 유기물질의 흡수와 흡착에 아주 유리하게 되어 있어, 병균감염, 종기를 치료하기 위한 배농용으로 효과가 크며, 정화 작용, 해독 효과 뿐만 아니라 얼굴용 마사지에도 사용되고 있고, 관절통, 근육통, 관절염, 셀룰라이트, 궤양, 벌레 물린데, 화상에도 효과적인 것으로 알려져 있다.In addition, illite has excellent characteristics such as heavy metal adsorption, toxic gas adsorption, far-infrared radiation, anion generation, etc., and its molecular structure is very advantageous for the absorption and adsorption of organic substances. It is also effective in cleansing and detoxifying effects as well as facial massage, and is known to be effective in joint pain, muscle pain, arthritis, cellulite, ulcers, insect bites, and burns.
뿐만 아니라, 벤토나이트는 운모와 같은 결정구조를 하는 단사정계에 속하는 광물인 몬모릴로나이트가 주로 들어있는 점토로서 백색, 회색, 담갈색, 담녹색 등을 나타내며 주물형의 결합제, 요업원료의 혼입제, 연고의 기초제 등 다양한 분야에 사용되고 있다.In addition, bentonite is clay containing mainly montmorillonite, a mineral belonging to the monoclinic system having a crystalline structure such as mica, and shows white, gray, light brown, and pale green color, and is found in casting type binder, ceramic raw material mixing agent, and ointment base. It is used in various fields.
벤토나이트 표면에는 피부에 좋은 양이온을 띈 천연미네랄들이 다량 존재하여 이들이 피부에 부착된 피지 및 노폐물 등과 같은 양이온들과 서로 교환성을 나타내는 양이온 교환능력이 매우 크고, 비표면적치가 월등히 높아 양이온 흡착성이 매우 크며, 물과 반응하여 약 15배까지 팽창하며 무게의 5배까지 물을 흡수하고, 고농축 천연미네랄이 풍부하게 함유한 점토로서 순수 천연 미용제로 유럽 및 미국, 일본 여성들의 사랑을 받고 있으며 미국 FDA에서는 모든 벤토나이트(몬모리노나이트)는 GRAS에 부문으로 분류하고, 벤토나이트는 음식물의 소화와 각종 질병(알레르기,치주염,식도의 연쇄 상구균,위궤양, 메슥거림, 항문직장출혈, 설사, 말벌한테 쏘인데, 무좀치료, 상처, 여드름, 부스럼, 여성의 효모균, 비듬, 어린이 발열, 가려움증) 등을 치료할 뿐만 아니라 피를 맑게 하며 신경계통의 스트레스를 덜어주어 신진대사의 촉진과 활력을 보강하며, 피부미용과 치료에 탁월한 효과를 나타내는 광물로서, 미국 정부가 인체에 필수적으로 요구된다고 권장하는 66가지 미량 미네랄을 모두 함유하고 있어 여러 분야에서 건강의 개선이 이루어졌다고 보고되고 있고, 찜질 습포, 머드팩, 입욕제, 스킨케어 등 외부적으로 사용하기도 하며, 체내에서는 물과 섞거나 민감한 미각을 갖고 있는 사람을 돕기 위하여 음식에 바르는데 사용하기도 하며, 최근에는 의료 분야 뿐만 아니라 화장품 분야에 사용되고 있다.Bentonite surface has a large amount of natural minerals with good cations on the skin, so it has a very high cation exchange capacity that shows exchangeability with cations such as sebum and wastes attached to the skin. It reacts with water, expands up to 15 times, absorbs water up to 5 times its weight, and is rich in highly concentrated natural minerals.It is a pure natural beauty agent and is loved by European, American, and Japanese women. Bentonite (Monmorino-Nite) is classified as a category in GRAS, and bentonite is caused by food digestion and various diseases (allergic, periodontitis, streptococcus of the esophagus, gastric ulcer, nausea, anal rectal bleeding, diarrhea, wasps, etc. Treatment, wounds, acne, swelling, female yeast, dandruff, fever, itching) However, it is a mineral that clears blood, relieves nervous system stress, enhances metabolism and enhances vitality, and has excellent effects on skin care and treatment. It contains 66 trace minerals that the US government recommends as essential to the human body. It has been reported to improve health in various fields, and it is also used externally such as poultice packs, mud packs, baths, skin care, etc. In the body, foods to help people with water or sensitive tastes It is also used to apply, and recently it is used in the cosmetic field as well as the medical field.
보통 물은 35개 내외의 물분자가 연결되어 대단히 큰 클러스터를 이루고 있으며, 아황산가스, 탄산가스, 일산화탄소, 염소 가스 등이 물에 녹아 들어가면 이것들이 물분자의 클러스터 사이에 붙어 엉키게 될 뿐만 아니라 이들 가스류가 물에 용해되어 황산, 아황산, 탄산, 염산 등으로 되면서 물을 산성화시키고, 수은, 납, 카드뮴, 알루미늄을 비롯한 유독 중금속류도 클러스터에 엉키게 된다. 이렇게 물을 산성화시키는 가스류나 유독금속을 포함하고 있는 클러스터가 큰 물은 인체에 유해한 효과를 나타낼 뿐만 아니라 본 발명에서는 산란계의 계란에 유해한 효과를 나타내는 성분들이 축적될 개연성이 있고 DHA 함량이 만족스럽지 못하며, 항산화물질과 셀레늄이 계란 내에 함유되는 효과가 발현되지 않게 된다.Normally, water is composed of about 35 water molecules, forming a very large cluster. When sulfur dioxide, carbon dioxide, carbon monoxide, and chlorine gas are dissolved in water, they are not only entangled between clusters of water molecules but also entangled. Gases are dissolved in water to make sulfuric acid, sulfurous acid, carbonic acid, hydrochloric acid, and acidify the water. Toxic heavy metals such as mercury, lead, cadmium, and aluminum are also entangled in the cluster. Such a large number of clusters containing gas or toxic metals that acidify the water not only have a harmful effect on the human body, but also in the present invention are likely to accumulate components exhibiting a deleterious effect on eggs of the laying hens, and the DHA content is not satisfactory. The effects of antioxidants and selenium in eggs are not expressed.
따라서, 본 발명에서는 4 ~ 14㎛대의 원적외선방사, 자화처리, 초음파처리 등을 통하여 물분자의 클러스터를 5 ~ 6개의 분자로 세분화하여 물분자의 클러스터 사이에 엉키어있던 유독가스를 공중으로 날려보내고 중금속류는 침전시켜 상등액만을 취한 클러스터화된 물을 사용한다.Therefore, in the present invention, the cluster of water molecules is subdivided into 5-6 molecules through far-infrared radiation, magnetization, and ultrasonic treatment in the range of 4 to 14 μm to blow toxic gases entangled between the clusters of water molecules into the air. Heavy metals are precipitated using clustered water with supernatant only.
클러스터화된 물은 공지된 다양한 방법으로 제조 가능하고, 공지된 안정화 방법으로 안정화시킨 것을 사용하는 것이 바람직하며, 클러스터화되지 않은 물을 본 발명에서 사용할 경우에는 유용 성분의 계란 내 함유 효과가 만족스럽지 못한 문제점이 있다.The clustered water can be prepared by a variety of known methods, and it is preferable to use those stabilized by a known stabilization method. When the non-clustered water is used in the present invention, the effect of containing the useful components in eggs is not satisfactory. There is a problem.
본 발명에 있어서 음용수의 제조에 사용되는 토르말린, 일라이트 또는 벤토나이트는 원적외선을 방사하여 물을 활성화시켜 닭이 물을 음용시 사료에 함유된 유용 성분들이 계란 내에 용이하게 함유되도록 하는 기능을 한다.In the present invention, tourmaline, illite or bentonite used in the preparation of drinking water functions to radiate far infrared rays to activate water so that chickens easily contain useful ingredients contained in feed when drinking water.
상기 토르말린, 일라이트 또는 벤토나이트는 황산반토 처리를 행하여 사용하는 데, 황산반토를 처리하는 이유는 황산반토가 갖는 강한 응집력과 항균력을 이용하여 토르말린, 일라이트 또는 벤토나이트의 표면 및 내부에 존재 가능성이 있는 미생물들을 살균하고 미분말을 응집시켜 제거하기 위함이다.The tourmaline, illite or bentonite is used by alumina sulfate treatment, and the reason for treating alumina sulfate is that it may be present on the surface and inside of the tourmaline, illite or bentonite by using the strong cohesive force and the antibacterial activity of the alumina sulfate. This is to sterilize microorganisms and to aggregate and remove fine powder.
상기 황산반토 처리는 토르말린, 일라이트 또는 벤토나이트를 물에 투입한 후, 토르말린, 일라이트 또는 벤토나이트 중량에 대하여 0.05 ~ 0.5중량%의 황산반토를 투입하여 1시간 정도 정치한 다음, 여과하여 토르말린, 일라이트 또는 벤토나이트만을 분리하고 수세 및 건조하는 방법으로 행한다.In the alumina sulfate treatment, tourmaline, illite or bentonite is added to water, and then 0.05 to 0.5% by weight of alumina sulfate is added to the tourmaline, illite or bentonite, and allowed to stand for about 1 hour. Only light or bentonite is separated, washed with water and dried.
황산반토 처리된 토르말린, 일라이트 또는 벤토나이트 중 적어도 1종 이상을 클러스터화된 물에 투입하여 미네랄을 용출시킨 미네랄수에 알칼리이온수를 혼합하여 pH를 6.5 ~ 7.0으로 조절하는 방법으로 음용수를 제조한다.Drinking water is prepared by adding at least one of tourmaline, illite, or bentonite treated with alumina sulfate to clustered water, mixing alkaline ionized water with the eluted mineral water, and adjusting the pH to 6.5 to 7.0.
상기의 황산반토 처리된 토르말린, 일라이트 또는 벤토나이트는 클러스터화된 물의 중량에 대하여 특별히 제한되는 것은 아니지만 30중량% 미만으로 투입하고 가볍게 교반하는 것이 효과적이다.The alumina sulfate treated tourmaline, illite or bentonite is not particularly limited based on the weight of the clustered water, but it is effective to add less than 30% by weight and stir lightly.
상기와 같이 미네랄을 용출시킨 미네랄수는 pH가 낮아 약한 산성을 띄기 때문에 그대로 산란계에 음용케 할 경우에는 산란계의 생체가 산성으로 전환되어 산란율이 저하되는 등의 문제점이 있으므로 알칼리이온수를 첨가하여 pH를 6.5 ~ 7.0으로 조절한다.Mineral water eluting minerals as described above has a weak acidity because the pH is low, so when drinking in the laying system as it is, there is a problem that the body of the laying system is converted to acidic acid, so that the scattering rate is lowered. Adjust from 6.5 to 7.0.
본 발명에서 사용되는 알칼리이온수는 알칼리금속염화물 및 알칼리토금속염화물로 구성되는 군으로부터 선택된 적어도 1종 이상의 화합물을 친수성(hydrophilic)인 효소(enzyme) 표면에 소수성(hydrophobic)인 폴리머(polymer)를 결합시켜서 양친매성(amphiphilic)인 계면활성효소(surface-active enzyme)과 클러스터화된 물의 혼합물에 투입하여 알칼리금속 또는 알칼리토금속을 용출시킨 것이다.Alkaline ionized water used in the present invention is to combine at least one compound selected from the group consisting of alkali metal chlorides and alkaline earth metal chlorides hydrophobic (hydrophobic) polymer on the surface of the hydrophilic enzyme (enzyme) Alkali or alkaline earth metals were eluted by adding them to a mixture of amphiphilic surface-active enzymes and clustered water.
상기의 알칼리금속염화물 및 알칼리토금속염화물로는 Li ,Na, K, Rb, Cs, Si, Al, Fe, Ca, Na, K, Mg의 염화물을 의미하는 것으로 1종 이상이 사용되어야 하고, 알칼리금속염화물 및 알칼리토금속염화물은 계면활성효소(surface-active enzyme)와 클러스터화된 물에 의해서 미네랄 입자가 생성된다.The alkali metal chlorides and alkaline earth metal chlorides refer to chlorides of Li, Na, K, Rb, Cs, Si, Al, Fe, Ca, Na, K, and Mg, and at least one of them should be used. Chlorides and alkaline earth metal chlorides produce mineral particles by surface-active enzymes and clustered water.
또한, 계면활성효소(surface-active enzyme)는 친수성(hydrophilic)인 효소(enzyme) 표면에 소수성(hydrophobic)인 폴리머(polymer)를 결합시켜서 양친매성(amphiphilic)나타내도록 한 것으로 알칼리금속염화물 및 알칼리토금속염화물의 활성화를 보조하는 역할을 하는 것으로, 클러스터화된 물의 중량에 대하여 0.1 ~ 3중량%의 양을 사용하는 것이 효과적이며, 계면활성 효소의 사용량이 클러스터화된 물의 중량에 대하여 0.1중량% 미만일 경우에는 알칼리금속염화물 및 알칼리토금속염화물의 활성화가 미약한 단점이 있고, 3중량%를 초과할 경우에는 경제적이지 못한 문제점이 있다.In addition, surface-active enzyme binds to hydrophilic enzyme surface to show amphiphilic by combining hydrophobic polymer with alkali metal chloride and alkaline earth metal. It is effective to support the activation of chloride, it is effective to use the amount of 0.1 to 3% by weight based on the weight of the clustered water, when the amount of the surfactant is less than 0.1% by weight relative to the weight of the clustered water There is a disadvantage that the activation of the alkali metal chloride and alkaline earth metal chloride is weak, there is a problem that is not economical when it exceeds 3% by weight.
상기와 같이 구성되는 음용수를 1일 산란계 마리당 100 ~ 200cc를 음용하게 한다. 즉, 통상적으로 1마리의 산란계가 하루에 100 ~ 200cc의 물을 음용하는 것을 기준으로 일반 물 대신에 본 발명에 따른 음용수를 공급한다.Drinking water configured as described above is to drink 100 ~ 200cc per laying hens. In other words, one laying hen normally supplies drinking water according to the present invention instead of ordinary water on the basis of drinking 100 to 200 cc of water per day.
본 발명에 따른 음용수를 산란계에 음용케하고 무항생제 사료 중량에 대하여 일라이트 또는 벤토나이트 분말 1 ~ 5%가 함유된 사료를 식이케하면 계란 특유의 비린내가 없어지며, 계란 내부에 다량의 DHA를 함유하게 되고, 시료에 함유되는 유용 성분들이 계란 내부에 축적되도록 한다.Drinking the drinking water according to the present invention in laying hens and dieting the feed containing 1 to 5% of illite or bentonite powder relative to the weight of the non-antibiotic feed will eliminate the fishy characteristic peculiar to eggs, containing a large amount of DHA inside the egg And the useful components contained in the sample accumulate inside the eggs.
음용수의 제조에 사용되는 일라이트 또는 벤토나이트와는 달리 무항생제 사료 중량에 대하여 일라이트 또는 벤토나이트 분말 1 ~ 5%가 함유되도록 한다.Unlike illite or bentonite, which is used to make drinking water, it should contain 1 to 5% of illite or bentonite powder based on the weight of non-antibiotic feed.
뿐만 아니라, 무항생제 사료 중량에 대하여 셀레늄화합물 0.01 ~ 1% 및 아스타산친(astaxanthin : 3,3'-dihydroxy-β-β-carotene-4,4'-dione(3,3'-디하이드록시-β-β-카로틴-4,4'-디온)) 0.01 ~ 1%를 혼합한 사료를 식이케하고, 필요에 따라 무항생제 사료 중량에 대하여 오징어, 보리, 파프리카, 자고, 서리태, 강황, 당근, 천연, 서리, 쑥, 뽕잎, 시금치, 흑미, 오징어먹물, 검은깨, 쓴메밀, 백화사설초, 꾸지뽕나무 각각의 분말로 구성되는 군으로부터 선택된 분말을 적어도 1종 이상 혼합한 보조 사료 1 ~ 2%를 혼합하여 식이케한다.In addition, 0.01-1% selenium compound and astaxanthin (3,3'-dihydroxy-β-β-carotene-4,4'-dione (3,3'-dihydroxy-β) based on the weight of the antibiotic-free feed -β-carotene-4,4'-dione)) 0.01 to 1% of the feed is dieted, and if necessary, the weight of the non-antibiotic feed squid, barley, paprika, sleeping, frosted, turmeric, carrot, natural 1 ~ 2% of supplementary foods mixed with at least one powder selected from the group consisting of frost, wormwood, mulberry leaf, spinach, black rice, squid ink, black sesame, bitter buckwheat, white hoe sesame, Make it diet.
상기 셀레늄화합물 및 아스타산친은 소량으로 사료에 첨가되어 공급되고, 사료를 산란계가 식이하게되면 계란에 다량의 셀레늄화합물 및 아스타산친이 함유되며, 셀레늄화합물과 아스타산친이 무항생제 사료 중량에 대하여 각각 0.01중량% 미만으로 첨가되면 계란에 함유되는 셀레늄화합물과 아스타산친의 양이 소량이어서 만족스럽지 못한 문제점이 있고, 1중량%를 초과하는 양으로 첨가될 경우에는 첨가량의 상승에 따른 셀레늄화합물과 아스타산친 함유량의 상승 효과가 미약하여 경제적이지 못하다. 특히, 게란 내에 함유되는 셀레늄은 유기 셀레늄이어서 인체로의 흡수가 많이 이루어지는 효과가 있다.The selenium compound and astaxanthin are added to the feed in small amounts, and when the feed is laid, the egg contains a large amount of selenium compound and astaxanchin, and the selenium compound and astaxanthin are less than 0.01% by weight, respectively, based on the weight of the non-antibiotic feed. If the amount of selenium compound and astaxanthin contained in the egg is small, it is not satisfactory. If it is added in an amount exceeding 1% by weight, the synergistic effect of the content of selenium compound and astaxanthin according to the increase of the addition amount is weak. It is not economical. In particular, selenium contained in the geran is an organic selenium has an effect that the absorption into the human body is much.
한편, 오징어, 보리, 파프리카, 자고, 서리태, 강황, 당근, 천연, 서리, 쑥, 뽕잎, 시금치, 흑미, 오징어먹물, 검은깨, 쓴메밀, 백화사설초, 꾸지뽕나무 각각의 분말로 구성되는 군으로부터 선택된 분말을 적어도 1종 이상 혼합한 보조 사료는 음용수의 식이와 일라이트 또는 벤토나이트 분말의 식이로 인하여 산란계가 보조 사료의 유용 성분 또는 색소를 계란내로 전달하게 되어 계란의 난황이 다양한 색상으로 변화되며, 다양한 유용 성분을 함유하는 계란을 얻게 된다.On the other hand, from the group consisting of powder of squid, barley, paprika, sleeping, frosted, turmeric, carrot, natural, frost, mugwort, mulberry leaf, spinach, black rice, squid ink, black sesame, bitter buckwheat, white pear, In the supplementary food mixture of at least one selected powder, the egg yolk is changed to various colors as the laying hen delivers useful ingredients or pigments of the supplementary feed into the egg due to the diet of drinking water and the diet of illite or bentonite powder. You will get eggs containing various useful ingredients.
상기에서 언급된 보조 사료의 성분 이외에 유용 성분이나 색소가 계란 내부로 전달되어 함유될 수 있는 것들은 모두 사용 가능하며, 반복 실험을 통하여 성분들을 적절히 조합하면 난황이 다양한 색상으로 착색된 계란을 얻게 된다.In addition to the components of the above-mentioned supplementary feed, all the useful ingredients or pigments that can be delivered and contained inside the egg can be used, and through repeated experiments, the eggs are colored in various colors when yolk is properly combined.
다음의 실시예는 본 발명을 좀 더 상세히 설명하는 것이지만, 본 발명의 범주를 한정하는 것은 아니다.The following examples illustrate the invention in more detail, but do not limit the scope of the invention.
실시예 1Example 1
벤토나이트를 10배량의 물에 투입한 후, 벤토나이트 중량에 대하여 0.05 ~ 0.5중량%의 황산반토를 투입하여 1시간 정도 정치한 다음, 여과하여 벤토나이트를 분리하고 수세 및 건조하여 황산반토처리된 벤토나이트를 얻는다.After bentonite was added to 10 times the amount of water, 0.05 to 0.5% by weight of alumina sulfate was added to the bentonite, and the mixture was allowed to stand for about 1 hour. After filtration, the bentonite was separated, washed with water and dried to obtain the bentonite treated with alumina. .
제조된 벤토나이트를 5 ~ 10㎛대의 원적외선방사를 통하여 물분자의 클러스터를 5 ~ 6개의 분자로 세분화한 클러스터화된 물에 투입하여 미네랄을 용출시켜 미네랄수를 얻고, 이에 Ca, Na, K, Mg의 염화물 및 친수성인 효소 표면에 소수성인 폴리머를 결합시켜서 양친매성으로 변환시킨 계면활성효소를 클러스터화된 물에 투입하여 미네랄을 용출시킨 알칼리이온수를 혼합하여 pH를 6.5 ~ 7.0으로 조절한 음용수를 1일 산란계 마리당 150cc를 음용하게 한다.The prepared bentonite is introduced into clustered water, which is divided into clusters of 5 to 6 molecules of water molecules through far-infrared radiation in the range of 5 to 10 ㎛, and the minerals are eluted to obtain mineral water. Thus, Ca, Na, K, Mg Drinking water adjusted to pH 6.5 ~ 7.0 by mixing alkali ion water eluted with minerals eluted by combining the hydrophobic polymer on the surface of chloride and hydrophilic enzyme of Drink 150cc per laying hen.
또한, 무항생제 사료 중량에 대하여 벤토나이트 분말 2%, 셀레늄화합물 0.1%, 아스타산친 0.1%, 오징어, 보리, 파프리카, 자고, 서리태 분말을 동량으로 혼합한 보조 사료 1%를 혼합하여 1일 산란계 마리당 120g을 식이케하고, 15일 경과후 산란한 계란을 수득하였다.In addition, 120 g per day of laying hens were mixed with 2% bentonite powder, 0.1% selenium compound, 0.1% astaxanthin, 0.1% astaxanthin, 1% supplementary feed mixed with squid, barley, paprika, sleeping and frosted powder. After 15 days, the eggs were laid.
수득된 계란을 대전 소재의 중부대학교 산학협력단에 의뢰하여 성분을 분석하여 표 1 및 도 1에 기재 및 도시하였고, 4개의 계란(A, B, C, D)에 대한 U.V 측정 결과를 나타내는 그래프를 도 2에 도시하였고, 계란의 난황을 손으로 집는 상태의 사진, 난황에 이쑤시개를 꽂은 상태의 사진, 일반계란과 본발명의 계란을 하나 의 그릇에 깨어 놓은 사진, 본 발명 계란의 난백을 보여주는 사진을 도 3 내지 도 6에 도시하였다.The obtained eggs were commissioned by the Jungbu University Industry-Academic Cooperation Foundation in Daejeon, Korea, and the components were analyzed and described in Table 1 and FIG. 1, and a graph showing UV measurement results for four eggs (A, B, C, and D) was shown. 2, a picture of the egg yolk picked by hand, a picture of the toothpick inserted into the egg yolk, a picture of the egg and egg of the present invention awakened in one bowl, a picture showing the egg white of the present invention egg Are shown in FIGS. 3 to 6.
또한, 수득된 계란을 일반인 50인에게 날로 먹게 한 후 비린내의 여부를 설문 조사한 결과, 모두 비린내가 없다고 대답하였다.In addition, after the obtained eggs were eaten by 50 people raw, the questionnaire surveyed whether they were fishy, and all answered that they were not fishy.
일반 계란에는 없는 성분임
Not found in regular eggs
* 상기 성분 이외에 22종 함유22 kinds of ingredients
도 1은 본 발명의 계란에 대한 성분 분석표이고,1 is a component analysis table for the egg of the present invention,
도 2는 본 발명의 계란에 대한 U.V 측정 결과를 나타내는 그래프이며,Figure 2 is a graph showing the U.V measurement results for eggs of the present invention,
도 3은 본 발명 계란의 난황을 손으로 집는 상태의 사진이고,Figure 3 is a photograph of a state of picking yolk yolk of the egg of the present invention,
도 4는 본 발명 계란의 난황에 이쑤시개를 꽂은 상태의 사진이며,Figure 4 is a photograph of the toothpick inserted into the egg yolk of the present invention,
도 5는 일반계란과 본발명의 계란을 하나의 그릇에 깨어 놓은 사진이고,Figure 5 is a photograph of the egg and the egg of the present invention awakened in one bowl,
도 6은 본 발명 계란의 난백을 보여주는 사진이다.Figure 6 is a photograph showing the egg white of the present invention egg.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090076042A KR101160730B1 (en) | 2009-08-18 | 2009-08-18 | The egg containing selenium, astaxanthin and DHA and its production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090076042A KR101160730B1 (en) | 2009-08-18 | 2009-08-18 | The egg containing selenium, astaxanthin and DHA and its production method |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110018538A KR20110018538A (en) | 2011-02-24 |
KR101160730B1 true KR101160730B1 (en) | 2012-06-28 |
Family
ID=43776148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090076042A KR101160730B1 (en) | 2009-08-18 | 2009-08-18 | The egg containing selenium, astaxanthin and DHA and its production method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101160730B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220070387A (en) | 2022-05-12 | 2022-05-31 | 정보헌 | Manufacturing method for enhanced mineral contents egg using deep ocean water and egg therof |
KR20230067352A (en) | 2021-11-09 | 2023-05-16 | 이현우 | Selenium-enriched eggs with anticancer Properties and Production Methods of the eggs |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102972336A (en) * | 2011-09-05 | 2013-03-20 | 敖汉远绿生态农牧业科技有限公司 | Breeding method of laying hens capable of laying high selenium eggs |
CN102972335A (en) * | 2011-09-05 | 2013-03-20 | 敖汉远绿生态农牧业科技有限公司 | Breeding method of laying hens capable of laying low cholesterol eggs |
CN102907573B (en) * | 2012-08-01 | 2013-09-04 | 中国农业大学 | Feed additive for improving DHA conversion efficiency and content in poultry egg, and application thereof |
CN104905027A (en) * | 2015-05-15 | 2015-09-16 | 贵州梦润鹌鹑有限公司 | Quail feed capable of enhancing immunity |
KR102035263B1 (en) * | 2019-04-22 | 2019-10-22 | 신경섭 | A composition for enriched egg shell |
KR102356727B1 (en) | 2019-12-11 | 2022-01-27 | 엠엔티이 주식회사 | Method of producing fuctional eggs with enhanced antioxidant |
KR102198158B1 (en) * | 2020-09-02 | 2021-01-04 | 이상국 | Manufacturing method of drinking water of livestock to create environment for revitalization of intestinal microorganism using natural mineral ion exchange |
CN112314522A (en) * | 2020-11-05 | 2021-02-05 | 柳州市宏华牧业有限责任公司 | Production method of eggs with low cholesterol content and high astaxanthin content |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0135673B1 (en) * | 1994-10-01 | 1998-04-22 | 한동근 | Hen's egg contains astaxanthin |
KR20020096345A (en) * | 2001-06-19 | 2002-12-31 | 주식회사 삼양사 | Special feed formula for laying hen to increase choline content of egg |
KR20050080380A (en) * | 2004-02-09 | 2005-08-12 | 주식회사 신한바이오켐 | Selenium enriched eggs and formula feed |
-
2009
- 2009-08-18 KR KR1020090076042A patent/KR101160730B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0135673B1 (en) * | 1994-10-01 | 1998-04-22 | 한동근 | Hen's egg contains astaxanthin |
KR20020096345A (en) * | 2001-06-19 | 2002-12-31 | 주식회사 삼양사 | Special feed formula for laying hen to increase choline content of egg |
KR20050080380A (en) * | 2004-02-09 | 2005-08-12 | 주식회사 신한바이오켐 | Selenium enriched eggs and formula feed |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230067352A (en) | 2021-11-09 | 2023-05-16 | 이현우 | Selenium-enriched eggs with anticancer Properties and Production Methods of the eggs |
KR20220070387A (en) | 2022-05-12 | 2022-05-31 | 정보헌 | Manufacturing method for enhanced mineral contents egg using deep ocean water and egg therof |
Also Published As
Publication number | Publication date |
---|---|
KR20110018538A (en) | 2011-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101160730B1 (en) | The egg containing selenium, astaxanthin and DHA and its production method | |
DE68919114T2 (en) | Undenatured whey protein concentrate. | |
CN103355543B (en) | Piglet forage | |
CN103355544A (en) | Lactation sow forage | |
CN105918607A (en) | Soybean whey protein composite powder and preparation method thereof | |
CN107028003A (en) | A kind of pork pig feed for lifting meat quality and preparation method thereof | |
CN106260534A (en) | A kind of marmoset artifical compound feed | |
CN105558887B (en) | Selenium-rich yolk powder and its production method | |
CN107439930A (en) | A kind of fast food various grains gruel | |
CN103689089A (en) | Pollen and almond powder beverage and preparation method thereof | |
KR101253342B1 (en) | Composition Vitamin With Dry Laver | |
KR100585970B1 (en) | Method for rearing duck and meat therefor | |
LT5676B (en) | Spirulina in chocolade | |
Menkovska | The newest experience with effervescent tablets containing royal jelly as functional food on packing, dosage and synergistic action in prevention, prophylaxis and healing. | |
CN1315403C (en) | Instant noodle and its preparing method | |
CN106387340A (en) | High-zinc selenium-enriched additive for laying hen feed, laying hen feeding method and selenium-enriched high-zinc eggs | |
CN111374239A (en) | Nutritional feed for eels and preparation method thereof | |
KR102665874B1 (en) | Feed composition for improving joint, skin and intestinal health of companion animals | |
KR102356727B1 (en) | Method of producing fuctional eggs with enhanced antioxidant | |
CN107432367A (en) | Improve the feed of pirarucu survival rate | |
CN1315391C (en) | Milk powder and its preparing method | |
CN105766719A (en) | Breeding method for preventing and controlling ciliophora disease of mandarin fish | |
KR20070037556A (en) | Colostrum rice and colostrum composition containing colostrum | |
KR101822470B1 (en) | Method for health food using Flaxseed and Garlic | |
Chuluun et al. | The secret to longevity and sustainable environmental development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20150602 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160621 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170613 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180510 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190618 Year of fee payment: 8 |